arrow
K

Karla M. Tamez-Torres

instituto nacional de ciencias médicas y nutricion salvador zubiran
H指数:10
被引数:534

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comparison of Two Strategies for Preventing Cytomegalovirus Disease in Solid Organ Transplant Recipients

两种预防实体器官移植受者巨细胞病毒疾病策略的比较

2026-09-250
PRE
Clinical characteristics of patients with extrapulmonary and disseminated tuberculosis: a 23-year retrospective cohort study in non-HIV patients without pharmacological immunosuppression

非HIV、无药物免疫抑制患者的肺外及播散性结核的临床特征:一项为期23年的回顾性队列研究

2026-09-090
OAAI
Development of a new clinical prediction rule for candidaemia

开发新的念珠菌病临床预测规则

2026-01-080
OAAI
Distinct Clinical Features of Extrapulmonary and Disseminated Tuberculosis in HIV- and Non-HIV-Associated Immunosuppression: A Retrospective Cohort Study

HIV相关与非HIV相关免疫抑制患者中,肺外结核和播散性结核的特异性临床特征:一项回顾性队列研究

2025-04-250
OA
Rapid Detection of Carbapenemases Using NG-Test® CARBA 5 in Positive Blood Cultures: A Diagnostic Test Study
2024-11-202
OA
Nirmatrelvir/ritonavir and remdesivir against symptomatic treatment in high-risk COVID-19 outpatients to prevent hospitalization or death during the Omicron era: a propensity score-matched study

Nirmatrelvir/利托那韦和remdesivir对抗高危新型冠状病毒肺炎门诊患者的对症治疗,以防止Omicron时代的住院或死亡: 倾向评分匹配研究

2024-03-263
OAAI
Complete remission with histamine blocker in a patient with intractable hyperadrenergic postural orthostatic tachycardia syndrome secondary to long coronavirus disease syndrome

长期冠状病毒疾病综合征继发的顽固性高肾上腺素能姿势性直立性心动过速综合征患者使用组胺阻滞剂完全缓解

2024-03-080
OAAI
Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial
2023-07-280
OAAI
Predictors of Mortality in Patients with Infections Due to Carbapenem-Resistant Gram-Negative Bacteria

耐碳青霉烯类革兰氏阴性菌感染患者死亡率的预测因素

2023-06-294
OAAI
Risk Factors Associated with the Development of Hospital-Acquired Infections in Hospitalized Patients with Severe COVID-19
2023-06-271
OA
Early Outpatient Treatment With Remdesivir in Patients at High Risk for Severe COVID-19: A Prospective Cohort Study

在严重新型冠状病毒肺炎高危患者中使用Remdesivir进行早期门诊治疗: 一项前瞻性队列研究

2022-10-0623
OAAI
NAFLD determined by Dallas Steatosis Index is associated with poor outcomes in COVID-19 pneumonia: a cohort study
2022-02-0913
OA
Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study

地塞米松治疗重症和危重新型冠状病毒肺炎患者的预后: 一项前瞻性队列研究

2021-12-2114
OAAI
Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic

新型冠状病毒肺炎大流行医院转换期间的抗菌素耐药性模式和抗生素使用

2021-02-1136
OAAI